Retraction: “MiR-17–5p Up-Regulates YES1 to Modulate the Cell Cycle Progression and Apoptosis in Ovarian Cancer Cell Lines” (J Cell Biochem, (2015), (1050-1059), 10.1002/jcb.25060);MiR-17-5p Up-regulates YES1 to modulate the cell cycle progression and apoptosis in ovarian cancer cell lines

Journal of Cellular Biochemistry

Volumn 116, Issue 6, 2015, Pages 1050-1059

  Li, Lan ^a,b   He, Li ^a   Zhao, Jian Li ^a   Xiao, Jing ^a   Liu, Min ^a   Li, Xin ^a   Tang, Hua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Hospital Henan Province   (China)

Author keywords

CELL CYCLE; MICRORNA; MiR 17 5P; OVARIAN CANCER; TARGET GENE; YES1

Indexed keywords

CASPASE 3; MESSENGER RNA; MICRORNA; MICRORNA 17 5P; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; ONCOPROTEIN; UNCLASSIFIED DRUG; YAMAGUCHI SARCOMA VIRAL ONCOGENE HOMOLOG 1 PROTEIN; MIRN17 MICRORNA, HUMAN; PROTEIN KINASE YES; YES1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; OVARIAN CANCER CELL LINE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; UPREGULATION; CELL CYCLE; FLOW CYTOMETRY; GENETICS; METABOLISM; OVARY TUMOR; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; HUMANS; MICRORNAS; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-YES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84926651028     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.30132     Document Type: Erratum

References (29)

1. Bartel DP,. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Cloonan N, Brown MK, Steptoe AL, Wani S, Chan WL, Forrest AR, Kolle G, Gabrielli B, Grimmond SM,. 2008. The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol 9: R127.
3. Djuranovic S, Nahvi A, Green R,. 2011. A parsimonious model for gene regulation by miRNAs. Science 331: 550-553.
4. Donadeu FX, Schauer SN, Sontakke SD,. 2012. Involvement of miRNAs in ovarian follicular and luteal development. J Endocrinol 215: 323-334.
5. Gregersen LH, Jacobsen AB, Frankel LB, Wen J, Krogh A, Lund AH,. 2010. MicroRNA-145 targets YES and STAT1 in colon cancer cells. PloS ONE 5: e8836.
6. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM,. 2005. A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
7. Hossain A, Kuo MT, Saunders GF,. 2006. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol 26: 8191-8201.
8. Huang V, Place RF, Portnoy V, Wang J, Qi Z, Jia Z, Yu A, Shuman M, Yu J, Li LC,. 2012. Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res 40: 1695-1707.
9. Jovanovic M, Hengartner MO,. 2006. MiRNAs and apoptosis: RNAs to die for. Oncogene 25: 6176-6187.
10. Kleber S, Sancho-Martinez I, Wiestler B, Beisel A, Gieffers C, Hill O, Thiemann M, Mueller W, Sykora J, Kuhn A, Schreglmann N, Letellier E, Zuliani C, Klussmann S, Teodorczyk M, Grone HJ, Ganten TM, Sultmann H, Tuttenberg J, von Deimling A, Regnier-Vigouroux A, Herold-Mende C, Martin-Villalba A,. 2008. Yes and PI3K bind CD95 to signal invasion of glioblastoma. Cancer Cell 13: 235-248.
11. Lu S, Wang S, Geng S, Ma S, Liang Z, Jiao B,. 2012. Increased expression of microRNA-17 predicts poor prognosis in human glioma. J Biomed Biotechnol 2012: 970761.
12. Luo H, Zou J, Dong Z, Zeng Q, Wu D, Liu L,. 2012. Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma. Biochem J 442: 311-321.
13. Ma L, Teruya-Feldstein J, Weinberg RA,. 2007. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688.
14. Ma Y, Zhang P, Wang F, Zhang H, Yang Y, Shi C, Xia Y, Peng J, Liu W, Yang Z, Qin H,. 2012. Elevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene P130. Nat Commun 3: 1291.
15. Orom UA, Nielsen FC, Lund AH,. 2008. MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 30: 460-471.
16. Pena SV, Melhem MF, Meisler AI, Cartwright CA,. 1995. Elevated c-yes tyrosine kinase activity in premalignant lesions of the colon. Gastroenterology 108: 117-124.
17. Rao E, Jiang C, Ji M, Huang X, Iqbal J, Lenz G, Wright G, Staudt LM, Zhao Y, McKeithan TW, Chan WC, Fu K,. 2012. The miRNA-17 approximately 92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. Leukemia 26: 1064-1072.
18. Shan SW, Fang L, Shatseva T, Rutnam ZJ, Yang X, Du W, Lu WY, Xuan JW, Deng Z, Yang BB,. 2013. Mature miR-17-5p and passenger miR-17- 3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways. J Cell Sci 126: 1517-1530.
19. Shimakami T, Yamane D, Jangra RK, Kempf BJ, Spaniel C, Barton DJ, Lemon SM,. 2012. Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc Natl Acad Sci USA 109: 941-946.
20. Sun N, Zhang Q, Xu C, Zhao Q, Ma Y, Lu X, Wang L, Li W,. 2014. Molecular regulation of ovarian cancer cell invasion. Tumour Biol 35: 11359-11366.
21. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massague J,. 2008. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152.
22. Thomas SM, Brugge JS,. 1997. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13: 513-609.
23. Vasudevan S, Steitz JA,. 2007. AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. Cell 128: 1105-1118.
24. Vasudevan S, Tong Y, Steitz JA,. 2007. Switching from repression to activation: microRNAs can up-regulate translation. Science 318: 1931-1934.
25. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM,. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261.
26. Wei Q, Li YX, Liu M, Li X, Tang H,. 2012. MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells. IUBMB Life 64: 697-704.
27. Wu Q, Luo G, Yang Z, Zhu F, An Y, Shi Y, Fan D,. 2014. MiR-17-5p promotes proliferation by targeting SOCS6 in gastric cancer cells. FEBS Lett 588: 2055-2062.
28. Yu J, Ohuchida K, Mizumoto K, Fujita H, Nakata K, Tanaka M,. 2010. MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. Cancer Biol Ther 10: 748-757.
29. Zhang LY, Liu M, Li X, Tang H,. 2013. MiR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3). J Biol Chem 288: 4035-4047.